DIRECT DIAGNOSTICS - Key Persons
Job Titles:
- Leader
- Chief Dental Officer
For thirty-seven years, Dr. Tom Nabors has served as a leader in advancing oral microbiology, immunology, and the emerging field of Oral Systemic Health. Following a career in Dentistry, he launched Oral DNA in 2008, the first diagnostic laboratory to focus on the indemnification and diagnostic relevance of oral pathogens. The company was acquired by Quest Diagnostics in 2009 where Tom remained the Chief Dental Officer until 2012.
Peter is a proven sales professional and has extensive sales/sales management experience within the dental/medical community. He has been servicing dental/medical professionals for over 20+ years with his last 11 years focused on the launch and sales of biotech/nutraceutical products and services in both the "Business to Business" and "Direct to Consumer" channels.
Peter's primary focus with Direct Diagnostics will be the launch of the company's new testing technologies, including the HR5™ High Risk Pathogen salivary test. Peter has strong affiliations with numerous dental and medical organizations including, the American Academy of Oral Systemic Health, and earned his Bachelor of Science degree in Management Science from Bridgewater State University.
Phil Jones is a retired urologist and active biotechnology investor based Norman, Oklahoma with diverse business interests including medical, biotech, energy, ranching, and real estate ventures. He co-founded Norman Urology Associates and has served as president of the Norman Physician Hospital Organization and the Oklahoma State Urologic Association. He also directed the Strategic Planning Committee as a Board Member of the Norman Regional Hospital Trust Authority.
Dr. Jones served as the lead angel and board member of Selexys Pharmaceuticals, recently acquired by Novartis Pharmaceuticals, which developed a promising treatment for sickle cell anemia. He currently serves on the board of Tetherex Pharmaceuticals which is focused upon new treatments for thrombotic and inflammatory diseases.
Dr. Jones is skillfully advised in all phases of business and life by his attorney-wife Cathleen and is protected from his longhorn cattle by his ranch partners and sons, Colin of Norman, Oklahoma, and Logan of Austin, Texas.
Pravin is a microbiologist with deep knowledge and understanding of aerobic - anaerobic bacteria physiology, cultivation, and strain characterization with extensive experience in developing and optimizing microbiology, molecular biology, immunodiagnostics assays, and molecular diagnostics.
He has had extensive scientific research experience in academia and industry over the last 15 years. Pravin obtained his Ph.D. in Molecular Ecology, Microbiology & Biogeochemistry from the Max Planck Institute - Philipps University at Marburg, Germany. After which, he completed post-doctoral programs at University of Massachusetts-Amherst and University of California-Berkeley. He worked at Assembly Biosciences in San Francisco, California before joining Paratus Diagnostics.
Pravin has over thirty peer reviewed research publications in various international journals including Nature.
Dr. McKinney has been an active participant in a number of businesses that include founding member of Arbor House assisted livings, multiple home healthcare agencies, an accountable care organization, private allied health schools, Selexys Pharmaceuticals, board member and owner of Oklahoma State Bank.
He holds a MS in Chemistry from Texas A&M and a Doctor of Osteopathic Medicine from University of North Texas Health Science Center - Texas College Osteopathic Medicine. He completed a Medical Oncology Fellowship at the University of Texas M. D. Anderson Hospital and retired from practicing oncology in 2008. He and his wife Deborah live in Austin, Texas and have two adult children, one living in Austin and one in Santa Barbara, California.
Job Titles:
- CEO
- President
- Investor and Entrepreneur
Rob Donnelly is an investor and entrepreneur with 18 years of investment management, biotechnology, and corporate board experience. His former roles include principal investing and executive management across a diverse range of emerging companies.
In 1999, Rob was a founding principal of Genesis Park, a Houston-based venture capital and private equity fund that invested across industries and structures. His experience in venture includes life sciences, material sciences, and software; while his private equity interests cover buy-out, turn-around and value-add opportunities. Rob earned a B.S. in Biomedical Science from Texas A&M University and an M.B.A. in Finance from Southern Methodist University.